Intas Contributes two million tablets of hydroxychloroquine for Global Trials Against COVID-19 Medical Dialogues Bureau3 April 2020 10:15 AM ISTIntas will provide up to two million tablets of hydroxychloroquine to the trial, free of charge, along with two million tablets of matched placebo.
CDSCO issues regulatory pathway for R&D of IVD kit for diagnosis of COVID-19 Medical Dialogues Bureau24 March 2020 11:45 AM ISTDelhi: Through the recent notice Central Drugs Standard Control Organization(CDSCO), Directorate General of Health Services as apprised about the...
CDSCO to fast-track applications, issues regulatory pathway for R & D of drugs for COVID-19 Medical Dialogues Bureau22 March 2020 12:15 PM ISTDelhi: Through a recent notice Central Drugs Standard Control Organization(CDSCO) , Directorate General of Health Services has released the regulatory...
CDSCO updates procedure for issuance of WHO GMP Medical Dialogues Bureau15 March 2020 12:45 PM ISTNew Delhi: Through a recent notice Central Drugs Standard Control Organization (CDSC0), Directorate General of Health Services, has laid...
WHO warns of global shortage of medical equipment, surgical masks, protective gowns, gloves to fight coronavirus Medical Dialogues Bureau5 March 2020 3:14 PM ISTWashington: The World Health Organization (WHO) on Tuesday warned of a global shortage and price gouging for protective equipment to fight the...
Coronavirus: Restrictions imposed on the export of medical equipment to China Medical Dialogues Bureau24 Feb 2020 12:29 PM ISTNew Delhi: India said some restrictions were imposed on export of certain medical equipment to China in view of their short supply within the country...
Complaints against Anti TB Dept, RITES India, Central Medical Service Society dismissed by CCI Medical Dialogues Bureau16 Feb 2020 10:30 AM ISTThe order came after it was alleged that the Central Medical Service Society and RITES India had published tenders for procurement of anti-TB and...
Coronavirus: Gilead drug remdesivir raises hope for China trials Medical Dialogues Bureau14 Feb 2020 12:42 PM ISTA state-run Chinese research institute applied last week fora patent to use Gilead's experimental drug- remdesivir against the new coronavirus.
Siemens Healthineers supplies ultrasound machines, CT scanner to Wuhan hospitals Farhat Nasim2 Feb 2020 9:00 AM IST A spokesman for the separately listed Siemens subsidiary said on Friday the diagnostic machines (two ultrasound machines and a CT scanner) were...
Gilead offers to test Ebola drug remdesivir as new coronavirus treatment in China Medical Dialogues Bureau1 Feb 2020 12:38 PM IST Gilead Sciences Inc said it was also expediting laboratory testing of the antiviral drug, remdesivir, against samples of the new coronavirus, which...
Merck Ebola vaccine Ervebo to be available at lowest access price for poor nations Medical Dialogues Bureau24 Dec 2019 9:00 AM ISTThe vaccine, Ervebo, was approved by the U.S. Food and Drug Administration on Thursday, a month after Europe gave its nod to the vaccine, a move that...
Health Ministry, WHO join hands to redesignate NHSRC for development of medical devices Farhat Nasim4 Oct 2019 5:06 PM ISTThis year in collaboration with WHO's country office, NHSRC developed a guidance document for the health ministry's free diagnostics initiative to...
